Today's Rundown Featured Story | | | Thursday, February 21, 2019 Merck is making a $300 million move to acquire Immune Design, developers of a midphase immunotherapy for non-Hodgkin’s lymphoma, as well as vaccines for respiratory syncytial virus and peanut allergies. |
|
|
| This week's sponsor is Covance. | |  | Optimizing Protocol Design and Patient Enrollment Case Study:
Learn how Covance guided an emerging pharmaceutical company who was uncertain about how to balance the selection of the right patients for their trial endpoints with the ability to achieve rapid patient recruiting. Covance leveraged their extensive and proprietary data sources to make recommendations that helped the sponsor substantially reduce the risk of high screen failure rates. Download the Case Study now. |
Top Stories Thursday, February 21, 2019 Johnson & Johnson has joined AbbVie as a partner for Morphic Therapeutic and its small-molecule integrin platform, pledging up to $725 million to the cause. Thursday, February 21, 2019 Rachelle Jacques, who most recently was a senior vice president at Alexion, takes over from Alvin Shih, M.D., the former R&D head at Retrophin who signed on at Enzyvant in November 2016. Monday, February 18, 2019 The opioid crisis continues to dominate the headlines and while many solutions are being discussed, prevention is often overlooked. Reducing exposure to opioids after surgery through better pain management options can make an impact. Thursday, February 21, 2019 Life science VC MPM Capital is looking to boost funding for a select series of early-stage biotechs with a new $400 million fund. Wednesday, February 20, 2019 Pfizer’s neuroscience spinoff, Cerevel Therapeutics, is bringing on Otsuka’s Raymond Sanchez, M.D., to serve as its new chief medical officer and take forward development of its late-stage programs for Parkinson’s disease and epilepsy into phase 3. Wednesday, February 20, 2019 Another CAR T production facility is slated for the U.S. as a biotech moves down the road with a bucket full of cash and a fistful of candidates. But unlike currently approved CAR T treatments, Allogene Therapeutics is looking to use donated T cells that may simplify the very complex manufacturing processes. Resources Sponsored by: Blue Matter White paper outlining the key types of cell-based immunotherapies in oncology, as well as the development and commercial outlook for each. Sponsored by: AlphaSense It’s never been more challenging to stay on top of trends and innovation shaping the future of healthcare. Discover how AI can help competitive intelligence teams achieve more proactive strategies. Presented by: SDC If commonly used statistical phrases like two-sample t-test, difference in proportions, or hazard ratio intimidate you, join this webinar for an introduction to statistical analyses in clinical trials. Sponsored by: Patheon, part of Thermo Fisher Scientific When a biologics company prepares to launch a new product, it must forecast the manufacturing capacity it will need, factoring in its estimate of the size of future sales, the timing of the launch, the dosage of the product, its strategy for building its market and a host of other variables. Sponsored by: Oracle Health Sciences 92% of survey respondents make changes to their RTSM/IRT systems due to study changes. See what else puts a strain on their clinical trials. Download the Research Whitepaper. Sponsored by: Patheon, part of Thermo Fisher Scientific Download this whitepaper to learn more. Sponsored by: The Kinetix Group Explore how the pharma industry can adapt its approach to the changing healthcare marketplace in the era of the Quadruple Aim Sponsored by: Cofactor Genomics Learn how Health Expression Models provide increased sensitivity, specificity, and accuracy for characterizing immune response in solid tumor specimens. Sponsored by: BioAnalytix, Inc. This whitepaper reviews fundamental aspects of HCPs that pertain to biologic drug development and presents current and emerging approaches to HCP analysis. Sponsored by: Veradigm Clinical trials take too long and cost too much—here's what needs to change. Sponsored by: Reprints Desk, Inc. Go from Search to Full-Text Scientific Papers in a Single Click! Sponsored by: Blue Latitude Health This white paper consists of original data and expert interviews. Download it today for exclusive tools, tips and analysis on achieving launch excellence in challenging pharma markets. Sponsored by: Outer Edge Technology With FDA approval imminent, start-up Life Sciences company partners with an industry focused MSP to design and manage its regulated cloud-based infrastructure to speed time to market. Presented by: Veeva Share your thoughts on the life sciences industry's progress in improving study execution. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. | 
